nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A2—Carmustine—brain cancer	0.499	0.771	CbGbCtD
Thiabendazole—CYP1A2—Etoposide—brain cancer	0.148	0.229	CbGbCtD
Thiabendazole—Lansoprazole—CYP2C9—brain cancer	0.0132	1	CrCbGaD
Thiabendazole—Visual acuity reduced—Temozolomide—brain cancer	0.0082	0.0266	CcSEcCtD
Thiabendazole—Cholestasis—Temozolomide—brain cancer	0.00642	0.0208	CcSEcCtD
Thiabendazole—Visual impairment—Lomustine—brain cancer	0.00615	0.0199	CcSEcCtD
Thiabendazole—Liver injury—Temozolomide—brain cancer	0.0058	0.0188	CcSEcCtD
Thiabendazole—Coordination abnormal—Carmustine—brain cancer	0.00514	0.0167	CcSEcCtD
Thiabendazole—Hepatic failure—Hydroxyurea—brain cancer	0.00504	0.0163	CcSEcCtD
Thiabendazole—Leukopenia—Lomustine—brain cancer	0.00497	0.0161	CcSEcCtD
Thiabendazole—Coordination abnormal—Temozolomide—brain cancer	0.00497	0.0161	CcSEcCtD
Thiabendazole—Numbness—Etoposide—brain cancer	0.00471	0.0153	CcSEcCtD
Thiabendazole—Drowsiness—Procarbazine—brain cancer	0.00451	0.0146	CcSEcCtD
Thiabendazole—Sensory loss—Etoposide—brain cancer	0.00451	0.0146	CcSEcCtD
Thiabendazole—Jaundice—Procarbazine—brain cancer	0.0044	0.0143	CcSEcCtD
Thiabendazole—Anorexia—Lomustine—brain cancer	0.00432	0.014	CcSEcCtD
Thiabendazole—Haematuria—Procarbazine—brain cancer	0.0043	0.0139	CcSEcCtD
Thiabendazole—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00413	0.134	CbGpPWpGaD
Thiabendazole—Decreased appetite—Lomustine—brain cancer	0.00394	0.0128	CcSEcCtD
Thiabendazole—Hepatic failure—Temozolomide—brain cancer	0.00394	0.0128	CcSEcCtD
Thiabendazole—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00376	0.122	CbGpPWpGaD
Thiabendazole—Flushing—Procarbazine—brain cancer	0.00376	0.0122	CcSEcCtD
Thiabendazole—Chills—Procarbazine—brain cancer	0.00364	0.0118	CcSEcCtD
Thiabendazole—Drowsiness—Hydroxyurea—brain cancer	0.00349	0.0113	CcSEcCtD
Thiabendazole—Leukopenia—Procarbazine—brain cancer	0.00316	0.0102	CcSEcCtD
Thiabendazole—Convulsion—Procarbazine—brain cancer	0.00306	0.00991	CcSEcCtD
Thiabendazole—Confusional state—Procarbazine—brain cancer	0.0029	0.00941	CcSEcCtD
Thiabendazole—Vomiting—Lomustine—brain cancer	0.00288	0.00934	CcSEcCtD
Thiabendazole—Hyperglycaemia—Carmustine—brain cancer	0.00286	0.00926	CcSEcCtD
Thiabendazole—Chills—Hydroxyurea—brain cancer	0.00281	0.00912	CcSEcCtD
Thiabendazole—Hyperglycaemia—Temozolomide—brain cancer	0.00276	0.00895	CcSEcCtD
Thiabendazole—Anorexia—Procarbazine—brain cancer	0.00274	0.00889	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00271	0.00877	CcSEcCtD
Thiabendazole—Nausea—Lomustine—brain cancer	0.00269	0.00873	CcSEcCtD
Thiabendazole—Hypotension—Procarbazine—brain cancer	0.00269	0.00872	CcSEcCtD
Thiabendazole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00264	0.0853	CbGpPWpGaD
Thiabendazole—Somnolence—Procarbazine—brain cancer	0.00256	0.00829	CcSEcCtD
Thiabendazole—Hypoaesthesia—Carmustine—brain cancer	0.00252	0.00818	CcSEcCtD
Thiabendazole—Decreased appetite—Procarbazine—brain cancer	0.0025	0.00811	CcSEcCtD
Thiabendazole—Fatigue—Procarbazine—brain cancer	0.00248	0.00804	CcSEcCtD
Thiabendazole—Leukopenia—Hydroxyurea—brain cancer	0.00244	0.00792	CcSEcCtD
Thiabendazole—Visual impairment—Carmustine—brain cancer	0.00244	0.00792	CcSEcCtD
Thiabendazole—Hypoaesthesia—Temozolomide—brain cancer	0.00244	0.0079	CcSEcCtD
Thiabendazole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.0024	0.0776	CbGpPWpGaD
Thiabendazole—Feeling abnormal—Procarbazine—brain cancer	0.00237	0.00769	CcSEcCtD
Thiabendazole—Convulsion—Hydroxyurea—brain cancer	0.00237	0.00767	CcSEcCtD
Thiabendazole—Visual impairment—Temozolomide—brain cancer	0.00236	0.00765	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Procarbazine—brain cancer	0.00235	0.00763	CcSEcCtD
Thiabendazole—Flushing—Carmustine—brain cancer	0.00235	0.00763	CcSEcCtD
Thiabendazole—Erythema multiforme—Temozolomide—brain cancer	0.00232	0.00751	CcSEcCtD
Thiabendazole—Tinnitus—Temozolomide—brain cancer	0.00228	0.0074	CcSEcCtD
Thiabendazole—Abdominal pain—Procarbazine—brain cancer	0.00228	0.00738	CcSEcCtD
Thiabendazole—Flushing—Temozolomide—brain cancer	0.00227	0.00737	CcSEcCtD
Thiabendazole—Chills—Temozolomide—brain cancer	0.0022	0.00712	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00217	0.00702	CcSEcCtD
Thiabendazole—Jaundice—Etoposide—brain cancer	0.00213	0.0069	CcSEcCtD
Thiabendazole—Anorexia—Hydroxyurea—brain cancer	0.00212	0.00688	CcSEcCtD
Thiabendazole—Hypersensitivity—Procarbazine—brain cancer	0.00212	0.00687	CcSEcCtD
Thiabendazole—Vision blurred—Carmustine—brain cancer	0.00208	0.00674	CcSEcCtD
Thiabendazole—Asthenia—Procarbazine—brain cancer	0.00207	0.00669	CcSEcCtD
Thiabendazole—Pruritus—Procarbazine—brain cancer	0.00204	0.0066	CcSEcCtD
Thiabendazole—Vision blurred—Temozolomide—brain cancer	0.00201	0.00651	CcSEcCtD
Thiabendazole—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.00199	0.0643	CbGpPWpGaD
Thiabendazole—Somnolence—Hydroxyurea—brain cancer	0.00198	0.00642	CcSEcCtD
Thiabendazole—Leukopenia—Carmustine—brain cancer	0.00198	0.0064	CcSEcCtD
Thiabendazole—Diarrhoea—Procarbazine—brain cancer	0.00197	0.00638	CcSEcCtD
Thiabendazole—Dyspepsia—Hydroxyurea—brain cancer	0.00196	0.00636	CcSEcCtD
Thiabendazole—Hypoaesthesia—Etoposide—brain cancer	0.00195	0.00632	CcSEcCtD
Thiabendazole—Angioedema—Temozolomide—brain cancer	0.00195	0.00632	CcSEcCtD
Thiabendazole—Decreased appetite—Hydroxyurea—brain cancer	0.00194	0.00628	CcSEcCtD
Thiabendazole—Fatigue—Hydroxyurea—brain cancer	0.00192	0.00623	CcSEcCtD
Thiabendazole—Convulsion—Carmustine—brain cancer	0.00191	0.0062	CcSEcCtD
Thiabendazole—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00191	0.0618	CbGpPWpGaD
Thiabendazole—Leukopenia—Temozolomide—brain cancer	0.00191	0.00619	CcSEcCtD
Thiabendazole—Dizziness—Procarbazine—brain cancer	0.0019	0.00617	CcSEcCtD
Thiabendazole—Erythema multiforme—Etoposide—brain cancer	0.00185	0.00601	CcSEcCtD
Thiabendazole—Convulsion—Temozolomide—brain cancer	0.00185	0.00599	CcSEcCtD
Thiabendazole—Feeling abnormal—Hydroxyurea—brain cancer	0.00184	0.00595	CcSEcCtD
Thiabendazole—Vomiting—Procarbazine—brain cancer	0.00183	0.00593	CcSEcCtD
Thiabendazole—Flushing—Etoposide—brain cancer	0.00182	0.0059	CcSEcCtD
Thiabendazole—Confusional state—Carmustine—brain cancer	0.00182	0.00589	CcSEcCtD
Thiabendazole—Rash—Procarbazine—brain cancer	0.00182	0.00588	CcSEcCtD
Thiabendazole—Dermatitis—Procarbazine—brain cancer	0.00181	0.00588	CcSEcCtD
Thiabendazole—Headache—Procarbazine—brain cancer	0.0018	0.00585	CcSEcCtD
Thiabendazole—Chills—Etoposide—brain cancer	0.00176	0.0057	CcSEcCtD
Thiabendazole—Confusional state—Temozolomide—brain cancer	0.00176	0.00569	CcSEcCtD
Thiabendazole—Anaphylactic shock—Temozolomide—brain cancer	0.00174	0.00564	CcSEcCtD
Thiabendazole—Anorexia—Carmustine—brain cancer	0.00172	0.00556	CcSEcCtD
Thiabendazole—Nausea—Procarbazine—brain cancer	0.00171	0.00554	CcSEcCtD
Thiabendazole—Hypotension—Carmustine—brain cancer	0.00168	0.00545	CcSEcCtD
Thiabendazole—Anorexia—Temozolomide—brain cancer	0.00166	0.00538	CcSEcCtD
Thiabendazole—Hypersensitivity—Hydroxyurea—brain cancer	0.00164	0.00532	CcSEcCtD
Thiabendazole—Somnolence—Carmustine—brain cancer	0.0016	0.00519	CcSEcCtD
Thiabendazole—Asthenia—Hydroxyurea—brain cancer	0.0016	0.00518	CcSEcCtD
Thiabendazole—Decreased appetite—Carmustine—brain cancer	0.00157	0.00507	CcSEcCtD
Thiabendazole—Somnolence—Temozolomide—brain cancer	0.00155	0.00501	CcSEcCtD
Thiabendazole—Dyspepsia—Temozolomide—brain cancer	0.00153	0.00497	CcSEcCtD
Thiabendazole—Leukopenia—Etoposide—brain cancer	0.00153	0.00495	CcSEcCtD
Thiabendazole—Diarrhoea—Hydroxyurea—brain cancer	0.00152	0.00494	CcSEcCtD
Thiabendazole—Decreased appetite—Temozolomide—brain cancer	0.00151	0.0049	CcSEcCtD
Thiabendazole—Fatigue—Temozolomide—brain cancer	0.0015	0.00486	CcSEcCtD
Thiabendazole—Feeling abnormal—Carmustine—brain cancer	0.00148	0.00481	CcSEcCtD
Thiabendazole—Convulsion—Etoposide—brain cancer	0.00148	0.00479	CcSEcCtD
Thiabendazole—Dizziness—Hydroxyurea—brain cancer	0.00147	0.00478	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Carmustine—brain cancer	0.00147	0.00477	CcSEcCtD
Thiabendazole—Feeling abnormal—Temozolomide—brain cancer	0.00143	0.00465	CcSEcCtD
Thiabendazole—Abdominal pain—Carmustine—brain cancer	0.00142	0.00461	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Temozolomide—brain cancer	0.00142	0.00461	CcSEcCtD
Thiabendazole—Vomiting—Hydroxyurea—brain cancer	0.00142	0.00459	CcSEcCtD
Thiabendazole—Rash—Hydroxyurea—brain cancer	0.0014	0.00455	CcSEcCtD
Thiabendazole—Confusional state—Etoposide—brain cancer	0.0014	0.00455	CcSEcCtD
Thiabendazole—Dermatitis—Hydroxyurea—brain cancer	0.0014	0.00455	CcSEcCtD
Thiabendazole—Headache—Hydroxyurea—brain cancer	0.0014	0.00452	CcSEcCtD
Thiabendazole—Anaphylactic shock—Etoposide—brain cancer	0.00139	0.00451	CcSEcCtD
Thiabendazole—Abdominal pain—Temozolomide—brain cancer	0.00138	0.00446	CcSEcCtD
Thiabendazole—Anorexia—Etoposide—brain cancer	0.00133	0.0043	CcSEcCtD
Thiabendazole—Hypersensitivity—Carmustine—brain cancer	0.00133	0.0043	CcSEcCtD
Thiabendazole—Nausea—Hydroxyurea—brain cancer	0.00132	0.00429	CcSEcCtD
Thiabendazole—Hypotension—Etoposide—brain cancer	0.0013	0.00422	CcSEcCtD
Thiabendazole—Asthenia—Carmustine—brain cancer	0.00129	0.00419	CcSEcCtD
Thiabendazole—Hypersensitivity—Temozolomide—brain cancer	0.00128	0.00416	CcSEcCtD
Thiabendazole—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00127	0.041	CbGpPWpGaD
Thiabendazole—Asthenia—Temozolomide—brain cancer	0.00125	0.00405	CcSEcCtD
Thiabendazole—Somnolence—Etoposide—brain cancer	0.00124	0.00401	CcSEcCtD
Thiabendazole—Diarrhoea—Carmustine—brain cancer	0.00123	0.00399	CcSEcCtD
Thiabendazole—Pruritus—Temozolomide—brain cancer	0.00123	0.00399	CcSEcCtD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00122	0.0394	CbGpPWpGaD
Thiabendazole—Decreased appetite—Etoposide—brain cancer	0.00121	0.00392	CcSEcCtD
Thiabendazole—Fatigue—Etoposide—brain cancer	0.0012	0.00389	CcSEcCtD
Thiabendazole—Dizziness—Carmustine—brain cancer	0.00119	0.00386	CcSEcCtD
Thiabendazole—Diarrhoea—Temozolomide—brain cancer	0.00119	0.00386	CcSEcCtD
Thiabendazole—Dizziness—Temozolomide—brain cancer	0.00115	0.00373	CcSEcCtD
Thiabendazole—Feeling abnormal—Etoposide—brain cancer	0.00115	0.00372	CcSEcCtD
Thiabendazole—Vomiting—Carmustine—brain cancer	0.00115	0.00371	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Etoposide—brain cancer	0.00114	0.00369	CcSEcCtD
Thiabendazole—Rash—Carmustine—brain cancer	0.00114	0.00368	CcSEcCtD
Thiabendazole—Dermatitis—Carmustine—brain cancer	0.00113	0.00368	CcSEcCtD
Thiabendazole—Headache—Carmustine—brain cancer	0.00113	0.00366	CcSEcCtD
Thiabendazole—Vomiting—Temozolomide—brain cancer	0.00111	0.00359	CcSEcCtD
Thiabendazole—Abdominal pain—Etoposide—brain cancer	0.0011	0.00357	CcSEcCtD
Thiabendazole—Rash—Temozolomide—brain cancer	0.0011	0.00356	CcSEcCtD
Thiabendazole—Dermatitis—Temozolomide—brain cancer	0.0011	0.00355	CcSEcCtD
Thiabendazole—Headache—Temozolomide—brain cancer	0.00109	0.00353	CcSEcCtD
Thiabendazole—Nausea—Carmustine—brain cancer	0.00107	0.00347	CcSEcCtD
Thiabendazole—Nausea—Temozolomide—brain cancer	0.00103	0.00335	CcSEcCtD
Thiabendazole—Hypersensitivity—Etoposide—brain cancer	0.00103	0.00333	CcSEcCtD
Thiabendazole—Asthenia—Etoposide—brain cancer	0.000999	0.00324	CcSEcCtD
Thiabendazole—Pruritus—Etoposide—brain cancer	0.000985	0.00319	CcSEcCtD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000954	0.0309	CbGpPWpGaD
Thiabendazole—Diarrhoea—Etoposide—brain cancer	0.000953	0.00309	CcSEcCtD
Thiabendazole—Dizziness—Etoposide—brain cancer	0.000921	0.00298	CcSEcCtD
Thiabendazole—Vomiting—Etoposide—brain cancer	0.000886	0.00287	CcSEcCtD
Thiabendazole—Rash—Etoposide—brain cancer	0.000878	0.00285	CcSEcCtD
Thiabendazole—Dermatitis—Etoposide—brain cancer	0.000877	0.00284	CcSEcCtD
Thiabendazole—Headache—Etoposide—brain cancer	0.000873	0.00283	CcSEcCtD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000829	0.0268	CbGpPWpGaD
Thiabendazole—Nausea—Etoposide—brain cancer	0.000827	0.00268	CcSEcCtD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000825	0.0267	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000814	0.0263	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000669	0.0216	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000609	0.0197	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000526	0.017	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000519	0.0168	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000515	0.0167	CbGpPWpGaD
Thiabendazole—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.00044	0.0142	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000426	0.0138	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000366	0.0119	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000355	0.0115	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.00035	0.0113	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000281	0.00908	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000234	0.00756	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000226	0.00733	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000223	0.00723	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000211	0.00684	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.00019	0.00616	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000162	0.00524	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000149	0.00482	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000146	0.00471	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000146	0.00471	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000136	0.00441	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000135	0.00436	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000121	0.00393	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000103	0.00334	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.97e-05	0.00323	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	9.49e-05	0.00307	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	9.28e-05	0.003	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	9.28e-05	0.003	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.7e-05	0.00281	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.36e-05	0.00206	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2C9—brain cancer	6.07e-05	0.00197	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BSG—brain cancer	5.17e-05	0.00167	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—IDH1—brain cancer	4.44e-05	0.00144	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2C9—brain cancer	3.87e-05	0.00125	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.62e-05	0.00117	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ENO2—brain cancer	3.51e-05	0.00114	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BSG—brain cancer	3.29e-05	0.00107	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—IDH1—brain cancer	2.83e-05	0.000916	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.31e-05	0.000746	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ENO2—brain cancer	2.24e-05	0.000724	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CG—brain cancer	1.61e-05	0.000521	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CG—brain cancer	1.03e-05	0.000332	CbGpPWpGaD
